REMAP Periop: a randomised, embedded, multifactorial adaptive platform trial protocol for perioperative medicine to determine the optimal enhanced recovery pathway components in complex abdominal surgery patients within a US healthcare system
Jennifer Holder‐Murray(University of Pittsburgh), Aman Mahajan(University of Pittsburgh), Oscar C. Marroquin(University of Pittsburgh), Shawn T. Beaman(University of Pittsburgh), Joshua Knight(University of Pittsburgh), Scott Berry(Queen's University), Stephen A. Esper(University of Pittsburgh), Alison R. Althans(University of Pittsburgh), Elizabeth Lorenzi(Berry & Associates (United States)), Joseph S. DeRenzo(University of Pittsburgh), Nicholas J. Schott(University of Pittsburgh), Kert Viele(University of Kentucky), Kathirvel Subramaniam(University of Pittsburgh), William Garrard(UPMC Health System), Charles Luke(University of Pittsburgh), Todd J. Wilkinson(University of Pittsburgh), Luca La Colla(University of Pittsburgh), Miranda Masters(University of Pittsburgh), Ryan Ball(University of Pittsburgh), Katie Meister(University of Pittsburgh), Lindsay R. Berry(Berry & Associates (United States)), Brian A. Williams(UPMC Health System)
Cited by 8
Related Papers
Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis
|JAMA|2019|1.5k
Comparison of Antiarrhythmic Drug Therapy and Radiofrequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation
|JAMA|2010|1.2k
Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
|New England Journal of Medicine|2013|980
Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19
|JAMA|2020|884
A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer’s disease with lecanemab, an anti-Aβ protofibril antibody
|Alzheimer s Research & Therapy|2021|818